Newish (Beijing) Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $14.7M

  • Investors
  • 10

Newish (Beijing) General Information

Description

Developer of nucleic acid-based cancer therapeutics designed for early-stage treatment. The company utilizes a proprietary nucleic acid drug development platform to create targeted immunotherapy drugs, enabling the healthcare sector to access clinical-stage oncology treatments for early-stage cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Building B, Number 18, Xihuan South Road
  • Beijing Economic and Technological Development Area
  • Beijing, 100176
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1st Floor, Building B, Number 18, Xihuan South Road
  • Beijing Economic and Technological Development Area
  • Beijing, 100176
  • China
+86 010

Newish (Beijing) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Newish (Beijing) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B2) 12-Jun-2026 $14.7M Completed Generating Revenue
7. Later Stage VC 04-Aug-2025 Completed Generating Revenue
6. Later Stage VC (Series B1) 31-Mar-2025 Completed Generating Revenue
5. Later Stage VC 01-Feb-2024 Completed Generating Revenue
4. Later Stage VC 23-Oct-2023 Completed Generating Revenue
3. Later Stage VC (Series A) 03-Sep-2021 Completed Generating Revenue
2. Grant 09-Aug-2021 $463K Completed Generating Revenue
1. Grant 23-Aug-2019 $78.7K Completed Generating Revenue
To view Newish (Beijing)’s complete valuation and funding history, request access »

Newish (Beijing) Patents

Newish (Beijing) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022434560-A1 Use of ccl11 Pending 24-Jan-2022
CA-3240773-A1 Use of ccl11 Pending 24-Jan-2022
EP-4474396-A1 Use of ccl11 Pending 24-Jan-2022
EP-4474396-A4 Use of ccl11 Pending 24-Jan-2022
US-20260159563-A1 Use of ccl11 Pending 24-Jan-2022 A61K39/39
To view Newish (Beijing)’s complete patent history, request access »

Newish (Beijing) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newish (Beijing) Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kangcheng Capital Growth/Expansion Minority
New Frontier Group PE/Buyout Minority
Shanghai Zhiyue Investment Management Growth/Expansion Minority
Botong (Tianjin) Venture Capital Growth/Expansion Minority
Wuxi Capital PE/Buyout Minority
You’re viewing 5 of 10 investors. Get the full list »

Newish (Beijing) FAQs

  • When was Newish (Beijing) founded?

    Newish (Beijing) was founded in 2014.

  • Where is Newish (Beijing) headquartered?

    Newish (Beijing) is headquartered in Beijing, China.

  • What is the size of Newish (Beijing)?

    Newish (Beijing) has 35 total employees.

  • What industry is Newish (Beijing) in?

    Newish (Beijing)’s primary industry is Drug Discovery.

  • Is Newish (Beijing) a private or public company?

    Newish (Beijing) is a Private company.

  • What is Newish (Beijing)’s current revenue?

    The current revenue for Newish (Beijing) is .

  • How much funding has Newish (Beijing) raised over time?

    Newish (Beijing) has raised $26.2M.

  • Who are Newish (Beijing)’s investors?

    Kangcheng Capital, New Frontier Group, Shanghai Zhiyue Investment Management, Botong (Tianjin) Venture Capital, and Wuxi Capital are 5 of 10 investors who have invested in Newish (Beijing).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process